EverQuoteの空売り状況は、投資家がEverQuoteの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

EverQuote (NASDAQ:EVER) 株価情報, 空売り情報

EVERQUOTE INC - CLASS A

EverQuote

EverBank Financial

EverBank Financial Corp.

NYSE

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

EverQuote Inc

Everscale

EVERBRIDGE INC COM

EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD

EVEREST CONSOLIDATOR ACQUISITION CORP UNIT 1 COM CL A & 1/2 WT EXP

EVERGREEN CORP CL A

EVERGREEN CORP UNIT 1 CL A SHS & 1 WT EXP

EVERGREEN CORP WT EXP

EVERGREEN MARINE CORP by Evergreen Marine Corp. Ltd.

EVERGREEN PRODS GROUP LTD by EVERGREEN PRODS GROUP LTD.

EVER HARVEST INTL GRP by Ever Harvest International Group Inc.

Ever Harvest International Group Inc

EVER-GLORY INTL GROUP INC by Ever-Glory International Group, Inc.

Ever-Glory International Group Inc

EverCommerce Inc

EVERGEN INFRASTRUCTURE CP by EverGen Infrastructure Corp.

EverGen Infrastructure Corp

EverRise

Everbright Digital Holding Limited - Ordinary Shares

Everbright Digital Holding Ltd

Evercel Inc

Evercore Inc

Everdime Inc

Everest

EVEREST CONSOLIDATOR A by Everest Consolidator Acquisition Corporation

Everest Consolidator Acquisition Corp

Everest Group Ltd

EVEREST METALS CORP LTD by EVEREST METALS CORP LTD.

Everest Metals Corp Ltd

Evergold Corp

EVERGRANDE PPTY SVC GRP by Evergrande Property Services Group Limited

Evergrande Property Services Group Ltd

EVERGRANDE PPTY UNSP/ADR by Evergrande Property Services Group Limited

Evergreen Corp Units (1 Ord Class A & 1 War)

Evergreen Corp

EVERGREEN CORP A by Evergreen Corporation

EVERGREEN PRODS GROUP ADR by Evergreen Products Group Ltd

Evergreen Products Group Ltd

EVERGREEN SUSTAIN ENTPRS by Evergreen Sustainable Enterprises Inc.

Evergreen Sustainable Enterprises Inc

Evergy Inc

Everi Holdings Inc

Everipedia

Everlert Inc

Everock Inc

Eversource Energy

Everspin Technologies, Inc. - Common Stock

Everspin Technologies Inc

Evertec Inc

EVERTZ TECHNOLOGIES LTD by Evertz Technologies Ltd.

Evertz Technologies Ltd

Everus Construction Group, Inc. Common Stock

Everus Construction Group Inc

EVERYBODY LOVES LANGUAGES by EVERYBODY LOVES LANGUAGES CORP.

Everybody Loves Languages Corp

EVERYDAY PEOPLE FINL CORP by Everyday People Financial Corp.

Everyday People Financial Corp

EVERYTHING BLOCKCHAIN INC by Everything Blockchain, Inc.

Everything Blockchain Inc

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and raises the price target from $29 to $30.

News

Price Target

Analyst Ratings

EVER

JP Morgan Maintains Overweight on EverQuote, Raises Price Target to $30

4 analysts have shared their evaluations of EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.75, a high estimate of $38.00, and a low estimate of $29.00. This current average reflects an increase of 5.47% from the previous average price target of $32.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1746536536_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of EverQuote by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Cory Carpenter</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Michael Graham</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to EverQuote. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of EverQuote compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of EverQuote's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of EverQuote's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EVER/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EverQuote analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into EverQuote's Background</h2>
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
<h3>EverQuote: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: EverQuote's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 164.71%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: EverQuote's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 8.35%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): EverQuote's ROE excels beyond industry benchmarks, reaching 9.73%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 6.29%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying EverQuote: Insights From 4 Analyst Reviews

U.S. stock futures were lower this morning, with the Dow futures falling over 200 points on Tuesday.
Shares of Ichor Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICHR#NASDAQ">ICHR</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results and issued second-quarter <a href="https://www.benzinga.com/quote/ICHR/earnings">guidance below estimates</a>.
Ichor Hldgs reported quarterly earnings of 12 cents per share which missed the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $244.47 million which missed the analyst consensus estimate of $244.95 million.
Ichor Holdings shares dipped 14.8% to $17.75 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Hyperscale Data, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#NYSE">GPUS</a>) dipped 17.2% to $6.42 in pre-market trading. Hyperscale Data shares jumped 466% on Monday after the company issued FY25 sales guidance.</li>
<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) fell 13.3% to $2.16 in pre-market trading. Immutep shares jumped over 45% on Monday after the company provided updates for cohort B of its Tacti-003 Phase IIb trial.</li>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) fell 8.4% to $113.45 in pre-market trading. Palantir reported in-line earnings for its first quarter on Monday. Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates. The company also raised its full-year guidance.</li>
<li>Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) fell 7.7% to $17.30 in pre-market trading following downbeat quarterly earnings.</li>
<li>Arcus Biosciences, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) fell 7.1% to $8.31 in pre-market trading.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) fell 6.8% to $206.00 in today's pre-market trading after the company reported third-quarter results and issued fourth-quarter guidance with its midpoint below estimates.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) declined 5.1% to $25.00 in pre-market trading following first-quarter results.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) fell 5% to $475.00 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

CSTL

GPUS

ICHR

IMMP

PLTR

RCUS

VRTX

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Needham analyst Mayank Tandon reiterates EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and maintains $38 price target.

Reiteration

Needham Reiterates Buy on EverQuote, Maintains $38 Price Target

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.32 by 25 percent. This is a 700 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $166.63 million which beat the analyst consensus estimate of $158.08 million by 5.41 percent. This is a 82.98 percent increase over sales of $91.06 million the same period last year.

Earnings

Earnings Beats

UPDATE: EverQuote Q1 Adj. EPS $0.40 Beats $0.32 Estimate, Sales $166.63M Beat $158.08M Estimate

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) sees Q2 sales of $155.000 million-$160.000 million vs $150.36 million analyst estimate.

Guidance

EverQuote Sees Q2 Sales $155.000M-$160.000M vs $150.36M Est

Earnings Misses

EverQuote Q1 GAAP EPS $0.21, Sales $166.63M Beat $158.08M Estimate

ACEL

ADEA

ADUS

AESI

AMRC

AOMR

AORT

ARES

AROC

AXSM

BCRX

BCSF

BFAM

BNTX

BRBR

BRCC

BWXT

CERT

CORT

CRBG

CRGY

CTRA

DENN

DMRC

DORM

EKSO

ESCA

FANG

FRPT

GBDC

GECC

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSIC

HSII

HSTM

IART

INSP

IPAR

IRMD

JBTM

JELD

JRVR

LSCC

MATX

MYPS

NBIX

NGVT

NMFC

NSSC

NVTS

OCUL

OPAD

OTTR

PLMR

PLOW

PLYA

PRAA

PRIM

RAIL

RAND

Earnings Scheduled For May 5, 2025

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Barclays BCS: This major global banking and financial services company with more than 325 years of expertise in banking, and operating through an international network in nearly 40 countries and regions in Europe, the U.S., Africa and Asia, the company provides a wide range of financial services to individuals, corporations and institutions, has seen the Zacks Consensus Estimate for its current year earnings increasing 29% over the last 60 days.
<div class="chart_embed">
<h3>Barclays PLC Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/BCS/price-consensus-chart?icid=chart-BCS-price-consensus-chart"><img alt="Barclays PLC Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/a2/1740650708.png" style="height:283px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/BCS/price-consensus-chart?icid=chart-BCS-price-consensus-chart">Barclays PLC price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/BCS?icid=chart-BCS-price-consensus-chart">Barclays PLC Quote</a>
</div>
CareDx CDNA: This commercial stage company which develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients, has seen the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.
<div class="chart_embed">
<h3>CareDx, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/CDNA/price-consensus-chart?icid=chart-CDNA-price-consensus-chart"><img alt="CareDx, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/a2/1740650708.png" style="height:282px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/CDNA/price-consensus-chart?icid=chart-CDNA-price-consensus-chart">CareDx, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/CDNA?icid=chart-CDNA-price-consensus-chart">CareDx, Inc. Quote</a>
</div>
The Progressive PGR: This company which is one of the major auto insurers in the country, has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 day.
<div class="chart_embed">
<h3>The Progressive Corporation Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PGR/price-consensus-chart?icid=chart-PGR-price-consensus-chart"><img alt="The Progressive Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/df/1740650710.png" style="height:278px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PGR/price-consensus-chart?icid=chart-PGR-price-consensus-chart">The Progressive Corporation price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PGR?icid=chart-PGR-price-consensus-chart">The Progressive Corporation Quote</a>
</div>
EZCORP EZPW: This company which is engaged in establishing, acquiring, and operating pawnshops which function as convenient sources of consumer credit and as value-oriented specialty retailers of primarily previously owned merchandise, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
<div class="chart_embed">
<h3>EZCORP, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart"><img alt="EZCORP, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/b7/1740650711.png" style="height:283px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. Quote</a>
</div>
EverQuote EVER: This company which operates an online marketplace for consumers shopping for auto, home and renters and life insurance, has seen the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
<div class="chart_embed">
<h3>EverQuote, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EVER/price-consensus-chart?icid=chart-EVER-price-consensus-chart"><img alt="EverQuote, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/ce/1740650716.png" style="height:282px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EVER/price-consensus-chart?icid=chart-EVER-price-consensus-chart">EverQuote, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EVER?icid=chart-EVER-price-consensus-chart">EverQuote, Inc. Quote</a>
</div>
&nbsp;
You can see&nbsp;<a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">the complete list of today&#39;s Zacks #1 Rank (Strong Buy) stocks here</a>.
&nbsp;
<h2>5 Stocks Set to Double</h2>
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/4e87?add=1726&amp;adid=SYND_BENZ_ZU_5S2DREPORT_ZACKS1RANKADDITIONS_02272025_2420915&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915" style="font-weight:bold">Today, See These 5 Potential Home Runs &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_2420915&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=BCS&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_BCS&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">Barclays PLC (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/bcs#NYSE">BCS</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PGR&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_PGR&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">The Progressive Corporation (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/pgr#NYSE">PGR</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EZPW&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_EZPW&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">EZCORP, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EVER&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_EVER&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">EverQuote, Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/ever#NYSE">EVER</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CDNA&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_CDNA&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">CareDx, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/cdna#NASDAQ">CDNA</a>): Free Stock Analysis Report
<a href="https://www.zacks.com/commentary/2420915/new-strong-buy-stocks-for-february-27th?cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">This article originally published on Zacks Investment Research (zacks.com).</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Equities

Fintech news covering the emerging Financial Technology services sector

Fintech

Tech

CDNA

EZPW

New Strong Buy Stocks For February 27th

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Loop Capital raised Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) price target from $260 to $280. Loop Capital analyst Chris Dankert maintained a Hold rating. Rockwell Automation shares closed at $292.63 on Monday. <a href="https://www.benzinga.com/quote/ROK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies slashed the price target for Trex Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) from $81 to $71. Jefferies analyst Philip Ng maintained a Hold rating. Trex shares closed at $61.67 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/TREX/analyst-ratings">view this stock</a>.</li>
<li>Compass Point cut Core Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) price target from $26 to $20. Compass Point analyst Joe Flynn maintained a Buy rating. Core Scientific shares closed at $9.86 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/CORZ/analyst-ratings">view this stock</a>.</li>
<li>CIBC raised the price target for Nutrien Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) from $64 to $66. Nutrien maintained an Outperformer rating. Block shares closed at $52.20 on Monday. <a href="https://www.benzinga.com/quote/NTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised the price target for EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from $25 to $29. JP Morgan analyst Cory Carpenter maintained an Overweight rating. EverQuote shares closed at $20.15 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/EVER/analyst-ratings">view this stock</a>.</li>
<li>Macquarie increased Madison Square Garden Sports Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) price target from $240 to $250. Macquarie analyst Paul Golding maintained an Outperform rating. Madison Square Garden Sports shares settled at $202.86 on Monday. <a href="https://www.benzinga.com/quote/MSGS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM slashed Topgolf Callaway Brands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) price target from $16 to $11. Roth MKM analyst George Kelly reiterated a Buy rating. Topgolf Callaway Brands shares closed at $6.70 on Monday. <a href="https://www.benzinga.com/quote/MODG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>BMO Capital raised Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) price target from $500 to $515. BMO Capital analyst Andrew Strelzik maintained an Outperform rating. Domino&#8217;s shares closed at $455.64 on Monday.  <a href="https://www.benzinga.com/quote/DPZ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital lowered the price target for Owens Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) from $224 to $212. RBC Capital analyst Mike Dahl maintained an Outperform rating. Owens Corning shares settled at $162.89 on Monday. <a href="https://www.benzinga.com/quote/OC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler cut Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) price target from $1.5 to $1. Piper Sandler analyst Arvind Ramnani maintained an Underweight rating. Chegg shares closed at $1.56 on Monday. <a href="https://www.benzinga.com/quote/CHGG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43937701/how-to-earn-500-a-month-from-lowes-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Lowe&#8217;s Stock Ahead Of Q4 Earnings</a></li>
</ul>

CHGG

Core Scientific, Inc. - Class A Common Stock

CORZ

MODG

MSGS

TREX

Domino's Pizza To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday

U.S. stocks were mixed, with the Dow Jones gaining over 100 points on Tuesday.
Shares of Itron, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) rose sharply during Tuesday's session after the company reported <a href="https://www.benzinga.com/quote/ITRI/earnings">better-than-expected fourth-quarter financial results.</a>
Itron posted quarterly earnings of $1.35 per share, beating market estimates of $1.05 per share. The company's quarterly sales came in at $612.864 million beating estimates of $603.204 million.
Additionally, the company issued FY25 EPS guidance above estimates.
Itron shares jumped 9.7% to $101.57 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>AdaptHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares jumped 25.4% to $10.73 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 20.8% to $24.36 after the company reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance above estimates.</li>
<li>Dream Finders Homes, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) gained 19.8% to $25.16 following better-than-expected quarterly financial results..</li>
<li>FARO Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) jumped 18.2% to $31.99 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS guidance above estimates.</li>
<li>Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) gained 16.8% to $123.48 after the company reported better-than-expected quarterly EPS and sales.</li>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) jumped 15.4% to $16.28 after the company reported quarterly financial results and beat its adjusted EPS and revenue estimates.</li>
<li>JBT Marel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBTM#NYSE">JBTM</a>) gained 14.7% to $134.57 following fourth-quarter results.</li>
<li>DigitalOcean Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) rose 13.5% to $42.17 after the company reported better-than-expected fourth-quarter results.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) gained 13.2% to $29.84 after the company announced first Electric SUV.</li>
<li>Stantec Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STN#NYSE">STN</a>) gained 8.6% to $82.92 following quarterly results.</li>
<li>The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) gained 4.5% to $399.58 after the home improvement retailer reported its fourth-quarter 2024 results and provided its 2025 outlook.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43948819/intuit-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Intuit Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Intraday Update

AHCO

DOCN

FARO

GSHD

ITRI

Itron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and raises the price target from $25 to $29.

JP Morgan Maintains Overweight on EverQuote, Raises Price Target to $29

EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) shares are trading higher on Tuesday. On Monday, the company reported fourth-quarter results and issued first-quarter <a href="https://www.benzinga.com/pressreleases/25/02/g43925665/everquote-announces-fourth-quarter-and-full-year-2024-financial-results" target="_blank" rel="noreferrer noopener">revenue guidance above estimates</a>.
The company reported EPS of $0.33, missing the $0.39 estimate, while sales of $147.46 million exceeded the $133.86 million estimate.
EverQuote expects first-quarter FY25 sales of $155 million-$160 million vs. consensus of $136.86 million and <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">adjusted EBITDA of $19 million-$21 million</a>.
JPMorgan analyst Cory A. Carpenter raised the price forecast from $25 to $29 and reiterated an Overweight rating, reflecting upward estimate revisions and the <a href="https://www.benzinga.com/quote/EVER/analyst-ratings" target="_blank" rel="noreferrer noopener">removal of the 1&#215;1 consent overhang</a>.
The analyst said the company has continued the trend of exceeding expectations, with revenue surpassing the upper end of guidance by 8%, driven by auto carriers increasing customer acquisition spending late in the quarter.
EverQuote&#8217;s first-quarter guidance was 15% higher than Street estimates, partly due to fewer challenges from the vacated 1&#215;1 consent rule, added the analyst.
Carpenter wrote that while revenue growth was expected to normalize around 15%-20% through the year, he saw the potential for further upside as several carriers remained inactive and some states were still largely closed.
Also, Needham analyst Mayank Tandon maintained a Buy rating and raised the price forecast from $30 to $38.
Investors can gain exposure to the stock via Inspire Fidelis Multi Factor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDLS#NYSE">FDLS</a>).
EVER Price Action: EverQuote shares are up 18.71 % at $23.92 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43945075" target="_blank" rel="noreferrer noopener">Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Small Cap

Insurance

Northern Lights Fund Trust IV Inspire Fidelis Multi Factor ETF

FDLS

EverQuote Positioned For Growth As Auto Carriers Boost Customer Acquisition, Analyst Says

WIIM

EverQuote shares are trading higher after the company reported better-than-expected Q4 revenue results and issued Q1 revenue guidance above estimates.

In the last three months, 4 analysts have published ratings on EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for EverQuote, revealing an average target of $32.0, a high estimate of $38.00, and a low estimate of $25.00. No alteration is observed as the current average remains at the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1740484828_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of EverQuote by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Michael Graham</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Cory Carpenter</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Aaron Kessler</td>
<td>Raymond James</td>
<td>Maintains</td>
<td>Strong Buy</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to EverQuote. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of EverQuote compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of EverQuote's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of EverQuote's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EVER/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EverQuote analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering EverQuote: A Closer Look</h2>
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
<h3>Key Indicators: EverQuote's Financial Health</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: EverQuote's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 162.73%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: EverQuote's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.99% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 10.57%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): EverQuote's ROA stands out, surpassing industry averages. With an impressive ROA of 6.83%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: EverQuote's debt-to-equity ratio is below the industry average at 0.03, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Needham analyst Mayank Tandon maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $30 to $38.

Needham Maintains Buy on EverQuote, Raises Price Target to $38

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) sees Q1 sales of $155.000 million-$160.000 million vs $136.86 million analyst estimate.

Comments

EverQuote

空売り

EverQuote (NASDAQ:EVER) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル